Anti-NMDA Receptor Enphalitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anti-NMDA Receptor Enphalitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownNot Applicable

NCT02559089

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Anti-NMDA receptor encephalitis is the most common curable non-infectious autoimmune encephalitis，but because of the lack of recognition in the clinic, usually…

Location not specified400 participantsStarted 2015-05